We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Show complete data for human cells assay. The location(s) are highlighted in the illustration on the right.
Localized to the nucleoplasm.
RNA cell categoryi
The cell lines in the Human Protein Atlas have been analyzed by RNA-seq to estimate the transcript abundance of each protein-coding gene. The RNA-seq data was then used to classify all genes according to their cell line-specific expression into one of six different categories, defined based on the total set of all TPM values in all analyzed cell lines.
Protein evidence scores are generated from several independent sources and are classified as evidence at i) protein level, ii) transcript level, iii) no evidence, or iv) not available.
Evidence at protein level
Main locationi
The main location is characterized by presence in all tested cell lines and/or increased intensity compared to other locations. It is highlighted in the illustration to the right. If available, links to overrepresentation analyses in Reactome, a free, open-source, curated and peer reviewed biological pathway database, are provided. An analysis is done for the corresponding gene set of the proteome localizing to the main and additional locations of the protein on this page, respectively.
The location(s) are Enhanced based on analysis of GFP-tagged protein.
DATA RELIABILITY
Reliability scorei
A reliability score is set for all genes and indicates the level of reliability of the analyzed protein expression pattern based on available protein/RNA/gene characterization data. The reliability of the annotated protein expression data is also scored depending on similarity in immunostaining patterns and consistency with available experimental gene/protein characterization data in the UniProtKB/Swiss-Prot database.
Below is an overview of RNA expression data generated in the HPA project. The analyzed cell lines are divided into 12 color-coded groups according to the organ they were obtained from. By clicking the toolbars in the top right corner it is possible to sort the cell lines in the chart by different criteria: the organ and the origin that the cell line was obtained from, the category of the cell line according to cellosaurus, alphabetically or by descending RNA expression. Detailed information about a specific cell line can be accessed by hovering over the corresponding bar in the chart. The RNA-sequencing results generated in the HPA are reported as number of Transcripts per Kilobase Million (TPM). In the Human Protein Atlas a TPM value of 1.0 is defined as a treshhold for expression of the corresponding protein.
The cell lines in the Human Protein Atlas have been analyzed by RNA-seq to estimate the transcript abundance of each protein-coding gene. The RNA-seq data was then used to classify all genes according to their cell line-specific expression into one of six different categories, defined based on the total set of all TPM values in all analyzed cell lines.
Cell lines sorted after organ of phenotypic resemblance.
Cell lines sorted after biological source for establishment.
Cell lines sorted after the cell line category according to Cellosaurus.
Cell lines sorted on descending RNA expression.
Cell lines sorted alphabetically.
HUMAN CELLSi
The "human cells" section gives an overview about the subcellular location of the protein of interest obtained by indirect immunofluorescence microscopy, an antibody-based protein-visualization technique. The immunofluorescent analysis is carried out in three different cell lines, one of them always being U-2 OS. A selection of immunofluorescent images is displayed below. Three different organelle probes are displayed as different channels in the multicolor images - nucleus stained in blue, microtubules in red and ER in yellow. The antibody staining targeting the protein of interest is shown in green. By using the toggle channel buttons, the different channels can be turned on and off. For the selection of the images to compare, use the checkboxes next to the images at the bottom. Three images can be compared at a time. All images are clickable for an enlarged view. The selected image will appear in large size and miniature images with all other staining results for this gene will be listed at the top left of the image. The selected miniature image has an orange overlay. For cell structure reference, visit the cell dictionary.
Summaryi
Summary of the immunofluorescent analysis in all studied cell lines with all tested antibodies.
Localized to the nucleoplasm.
Main locationi
The main location is characterized by presence in all tested cell lines and/or increased intensity compared to other locations.
Nucleoplasm (enhanced)
Toggle channelsi
Three different organelle probes are displayed as different channels in the multicolor images - nucleus stained in blue, microtubules in red and ER in yellow. The antibody staining targeting the protein of interest is shown in green. By using the "toggle channels"-buttons, the different channels can be turned on and off. The intensity toggle shows the pixel intensity range in 16 different colors for the selected channel. The object toggle shows the computational segmentation of the cells used for further analysis in the HPA project. For samples where cell cycle dependency for the protein is suggested according to a correlation assay the predicted cell cycle position of each cell is displayed when using the object toggle.
Low
High
G1
S
G2
M
N/A
Thumbnaili
Representative images for the assay. Three images can be compared at the same time. To change which images to compare, use the checkboxes next to the images below. All images are clickable for an enlarged view. The selected image will appear in large size and miniature images with all other staining results for this gene will be listed at the top left of the image. The selected miniature image has an orange overlay.
Antibodyi
Antibody used for analysis. Clicking the antibody ID links to the antibody validation page.
Cell linei
Cell line used for analysis. Read more about the cell lines in the Human Protein Atlas.
Locationi
Location(s) annotated in the corresponding cell line.
Single-cell variationi
As the images in the Cell Atlas provide single cell resolution, variations in protein expression patterns from cell to cell can be observed. A single-cell variation can either be observed in the intensity of the immunofluorescent signal or in the spatial distribution pattern of the protein. This column contains information about whether and for which of the annotated locations a single-cell variation pattern was manually annotated.
Cell cycle dependent variationi
A likely cause for single-cell variation in the immunofluorescent images is cell cycle dependency. This column contains information about whether the manually observed cell-to-cell variation pattern correlates with cell cycle progression.
The GFP section gives an overview of the colocalization of one or more antibodies with GFP-tagged target protein in HeLa cells. Read more about antibody validation by GFP colocalization. At the top of this section a selected image for each antibody is shown together with a validation summary for the antibody. A selection of immunofluorescent images using the antibody in cells expressing GFP-tagged target proteins as well as in untransfected HeLa cells is displayed below. The antibody staining, GFP and two organelle probes are displayed as different channels in the multicolor images. By using the "toggle channels"-buttons, the different channels can be turned on and off. To change which images to compare, use the checkboxes next to the images at the bottom. Three images can be compared at a time. All images are clickable for an enlarged view. The selected image will appear in large size and miniature images with all other staining results for this gene will be listed at the top left of the image. The selected miniature image has an orange overlay. For cell structure reference, visit the cell dictionary.
Antibodyi
Antibody used for analysis. Clicking the antibody ID links to the antibody validation page.
Summary of the recombinant expression validation. Antibodies are analyzed in HeLa cell lines stably expressing GFP-tagged target protein. The target protein can be tagged at either the N- or C-terminal end of the target gene; for some genes both versions are available. For each GFP validation assay a validation score is assigned based on colocalization of the antibody staining and the GFP-tagged protein.
C-terminal tag BAC cell line: 5379 Enhanced: Antibody staining overlaps with GFP tagged protein
Toggle channelsi
Two different organelle probes are displayed as different channels in the multicolor images - nucleus stained in blue and microtubules in red. The HPA-antibody staining targeting the protein of interest is shown in green and the staining of the GFP-tagged protein in purple. By using the "toggle channels"-buttons, the different channels can be turned on and off. The intensity toggle shows the pixel intensity range in 16 different colors for the selected channel.
Low
High
G1
S
G2
M
N/A
Thumbnaili
Representative images for the assay. Three images can be compared at the same time. To change which images to compare, use the checkboxes next to the images below. All images are clickable for an enlarged view. The selected image will appear in large size and miniature images with all other staining results for this gene will be listed at the top left of the image. The selected miniature image has an orange overlay.
Antibodyi
Antibody used for analysis. Clicking the antibody ID links to the antibody validation page.
Cell linei
Cell line used for analysis. Read more about the cell lines in the Human Protein Atlas.
BAC idi
Read more about the BAC cell lines by going to the Hyman lab, who created and supplied the BAC cell lines with an assigned BAC id. The untransfected HeLa control cells are referred to as "normal".
Tagi
The GFP construct can be tagged to the target protein at either the N- or C-terminal, for some genes both versions are available.
Location antibody stainingi
Subcellular location(s) annotated for the HPA-antibody.
Location tagged proteini
Subcellular location(s) annotated for the GFP-staining.
Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.
The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. [provided by RefSeq, Jul 2008]
The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.
At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.
Under the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).
The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).
If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.
Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
MYC-001
MYC-002
MYC-003
MYC-004
MYC-005
MYC-006
MYC-201
PROTEIN INFORMATIONi
The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.
The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.
The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.
The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
A0A087WUS5 [Direct mapping] Myc proto-oncogene protein
Show all
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000320 [re-entry into mitotic cell cycle] GO:0001541 [ovarian follicle development] GO:0001701 [in utero embryonic development] GO:0002082 [regulation of oxidative phosphorylation] GO:0003677 [DNA binding] GO:0003690 [double-stranded DNA binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005737 [cytoplasm] GO:0006006 [glucose metabolic process] GO:0006351 [transcription, DNA-templated] GO:0006352 [DNA-templated transcription, initiation] GO:0006355 [regulation of transcription, DNA-templated] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006848 [pyruvate transport] GO:0006865 [amino acid transport] GO:0007007 [inner mitochondrial membrane organization] GO:0007346 [regulation of mitotic cell cycle] GO:0008134 [transcription factor binding] GO:0008283 [cell proliferation] GO:0008284 [positive regulation of cell proliferation] GO:0009611 [response to wounding] GO:0009812 [flavonoid metabolic process] GO:0010629 [negative regulation of gene expression] GO:0010918 [positive regulation of mitochondrial membrane potential] GO:0014911 [positive regulation of smooth muscle cell migration] GO:0019087 [transformation of host cell by virus] GO:0021854 [hypothalamus development] GO:0030728 [ovulation] GO:0032355 [response to estradiol] GO:0032869 [cellular response to insulin stimulus] GO:0035690 [cellular response to drug] GO:0036120 [cellular response to platelet-derived growth factor stimulus] GO:0043388 [positive regulation of DNA binding] GO:0043565 [sequence-specific DNA binding] GO:0044330 [canonical Wnt signaling pathway involved in positive regulation of wound healing] GO:0044344 [cellular response to fibroblast growth factor stimulus] GO:0044752 [response to human chorionic gonadotropin] GO:0045023 [G0 to G1 transition] GO:0045471 [response to ethanol] GO:0045787 [positive regulation of cell cycle] GO:0045821 [positive regulation of glycolytic process] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046325 [negative regulation of glucose import] GO:0046722 [lactic acid secretion] GO:0046982 [protein heterodimerization activity] GO:0046983 [protein dimerization activity] GO:0048146 [positive regulation of fibroblast proliferation] GO:0048661 [positive regulation of smooth muscle cell proliferation] GO:0060252 [positive regulation of glial cell proliferation] GO:0060548 [negative regulation of cell death] GO:0071300 [cellular response to retinoic acid] GO:0071322 [cellular response to carbohydrate stimulus] GO:0071346 [cellular response to interferon-gamma] GO:0071347 [cellular response to interleukin-1] GO:0071364 [cellular response to epidermal growth factor stimulus] GO:0071378 [cellular response to growth hormone stimulus] GO:0071391 [cellular response to estrogen stimulus] GO:0071394 [cellular response to testosterone stimulus] GO:0071407 [cellular response to organic cyclic compound] GO:0071409 [cellular response to cycloheximide] GO:0071464 [cellular response to hydrostatic pressure] GO:0071966 [fungal-type cell wall polysaccharide metabolic process] GO:0097421 [liver regeneration] GO:1901857 [positive regulation of cellular respiration] GO:1903841 [cellular response to arsenite(3-)] GO:1903862 [positive regulation of oxidative phosphorylation] GO:1904385 [cellular response to angiotensin] GO:1904586 [cellular response to putrescine] GO:1904620 [cellular response to dimethyl sulfoxide] GO:1904628 [cellular response to phorbol 13-acetate 12-myristate] GO:1990646 [cellular response to prolactin] GO:1990858 [cellular response to lectin] GO:1990859 [cellular response to endothelin] GO:2001171 [positive regulation of ATP biosynthetic process]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006355 [regulation of transcription, DNA-templated]
H0YBG3 [Direct mapping] Myc proto-oncogene protein
Show all
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated]
H0YBT0 [Direct mapping] Myc proto-oncogene protein
Show all
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006355 [regulation of transcription, DNA-templated] GO:0046983 [protein dimerization activity]
E5RGD7 [Direct mapping] Myc proto-oncogene protein
Show all
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Transcription factors Basic domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Disease related genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle] GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000165 [MAPK cascade] GO:0000978 [RNA polymerase II core promoter proximal region sequence-specific DNA binding] GO:0001077 [transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding] GO:0001658 [branching involved in ureteric bud morphogenesis] GO:0002053 [positive regulation of mesenchymal cell proliferation] GO:0003677 [DNA binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005829 [cytosol] GO:0006112 [energy reserve metabolic process] GO:0006338 [chromatin remodeling] GO:0006351 [transcription, DNA-templated] GO:0006355 [regulation of transcription, DNA-templated] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006879 [cellular iron ion homeostasis] GO:0006974 [cellular response to DNA damage stimulus] GO:0007050 [cell cycle arrest] GO:0007219 [Notch signaling pathway] GO:0008134 [transcription factor binding] GO:0008284 [positive regulation of cell proliferation] GO:0010332 [response to gamma radiation] GO:0010468 [regulation of gene expression] GO:0015671 [oxygen transport] GO:0016579 [protein deubiquitination] GO:0032204 [regulation of telomere maintenance] GO:0032403 [protein complex binding] GO:0032873 [negative regulation of stress-activated MAPK cascade] GO:0034644 [cellular response to UV] GO:0035690 [cellular response to drug] GO:0042493 [response to drug] GO:0043066 [negative regulation of apoptotic process] GO:0043234 [protein complex] GO:0043280 [positive regulation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0044346 [fibroblast apoptotic process] GO:0045656 [negative regulation of monocyte differentiation] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046983 [protein dimerization activity] GO:0048146 [positive regulation of fibroblast proliferation] GO:0048147 [negative regulation of fibroblast proliferation] GO:0050679 [positive regulation of epithelial cell proliferation] GO:0051276 [chromosome organization] GO:0051782 [negative regulation of cell division] GO:0051973 [positive regulation of telomerase activity] GO:0060070 [canonical Wnt signaling pathway] GO:0070491 [repressing transcription factor binding] GO:0070848 [response to growth factor] GO:0070888 [E-box binding] GO:0090096 [positive regulation of metanephric cap mesenchymal cell proliferation] GO:1904837 [beta-catenin-TCF complex assembly] GO:2000573 [positive regulation of DNA biosynthetic process] GO:2001022 [positive regulation of response to DNA damage stimulus]
A0A087WUS5 [Direct mapping] Myc proto-oncogene protein
Show all
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Amplifications COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006355 [regulation of transcription, DNA-templated] GO:0046983 [protein dimerization activity]
The Human Protein Atlas project is funded
MENU
